Filter Results:
(471)
Show Results For
- All HBS Web
(708)
- News (190)
- Research (471)
- Events (1)
- Multimedia (24)
- Faculty Publications (440)
Show Results For
- All HBS Web
(708)
- News (190)
- Research (471)
- Events (1)
- Multimedia (24)
- Faculty Publications (440)
Sort by
- April 2005 (Revised August 2012)
- Supplement
MedCath Corporation (B)
By: Regina E. Herzlinger and Louisa Neissa
Supplements the (A) case. A rewritten version of an earlier case. View Details
Keywords: Medical Specialties; Market Entry and Exit; Service Delivery; Conflict and Resolution; Horizontal Integration; Medical Devices and Supplies Industry
Herzlinger, Regina E., and Louisa Neissa. "MedCath Corporation (B)." Harvard Business School Supplement 305-102, April 2005. (Revised August 2012.)
- August 2003 (Revised August 2024)
- Case
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
By: Regina E. Herzlinger and John McDonough
Many health care innovations appear successful; but fail. This is the first case in the Innovating Health Care course that investigates how to create successful health care innovations. It is part of the first module in the course. This module focuses on how to... View Details
Keywords: Three Pillars; Industry Analysis; Health Care and Treatment; Innovation and Invention; Innovation and Management; Medical Specialties; Health Industry
Herzlinger, Regina E., and John McDonough. "Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment." Harvard Business School Case 304-009, August 2003. (Revised August 2024.)
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
pharma," said HBS professor Regina Herzlinger, moderating a panel discussion titled "Pharma and Biotech—Where does Europe Stand in the World?" The discussion was held at the conference on November 22. At the start of the... View Details
- December 10, 2024
- Other Article
A New Model for Funding Healthcare Innovation
By: Regina E. Herzlinger and Duke Rohlen
Herzlinger, Regina E., and Duke Rohlen. "A New Model for Funding Healthcare Innovation." Harvard Business Review (December 10, 2024).
- October 2024 (Revised October 2024)
- Case
Parexel: Scaling Up and Industry Dynamics
By: Regina E. Herzlinger and Ben Creo
Through the lens of biopharmaceutical contract research organization (CRO) PAREXEL, this case traces the evolution of the firm as it reinvents itself in response to the transformation of the CRO sector from a small, secondary cluster of firms into a major player with... View Details
- January 2024
- Background Note
Evaluating Innovations in the Organization of Primary Care: What Type of Innovation Is It and How Well Does It Align with the Six Factors?
By: Regina E. Herzlinger and James Wallace
How can we evaluate if innovative health care ventures can do good—benefit society—and do well—become financially viable? This question is the topic of the first module in the Innovating in Health Care course book.
This note and "Health Stop (A): What Type... View Details
This note and "Health Stop (A): What Type... View Details
- January 2023
- Exercise
Identify the Health Care Venture
By: Regina E. Herzlinger and James Wallace
This case enables rapid learning of the key financial characteristics of many types of health care organizations and to diagnose their financial status. It is a surprisingly fun exercise (see the Teaching Note) accomplished by organizing groups of students that compete... View Details
Keywords: Health Care; Health Care Spending; Health Care Financing; Health Care Industry; Health Care Operations; Health Care Delivery; Health Care and Treatment; Financial Condition; Health Industry
Herzlinger, Regina E., and James Wallace. "Identify the Health Care Venture." Harvard Business School Exercise 323-061, January 2023.
- October 2022 (Revised September 2024)
- Case
Podimetrics: Next Steps for Diabetes Cases
By: Regina E. Herzlinger and Ben Creo
Podimetrics, a virtual care management company treating adults with acute diabetes, sat at the intersection of medical device technology, digital health, and health services. Its SmartMat had demonstrated that it could help prevent amputations and that people with... View Details
Keywords: Health Care; Health Care Delivery; Health Care Entrepreneurship; Health Care Outcomes; Diabetes; Chronic Disease; Chronic Illness; Health Care and Treatment; Health Disorders; Medical Specialties; Technological Innovation; Innovation Strategy; Product Development; Business Model; Customer Focus and Relationships; Medical Devices and Supplies Industry; Health Industry
Herzlinger, Regina E., and Ben Creo. "Podimetrics: Next Steps for Diabetes Cases." Harvard Business School Case 323-015, October 2022. (Revised September 2024.)
- March 2021
- Supplement
Humana (C) — Reorganization
By: Regina E. Herzlinger and Ashley Ifeadike
A summary of Humana's restructuring of its business around its pillars. View Details
Keywords: Health Care; Health Care Industry; Health Insurance; Health Care Operations; Health; Health Care and Treatment; Insurance; Operations; Restructuring; Health Industry
Herzlinger, Regina E., and Ashley Ifeadike. "Humana (C) — Reorganization." Harvard Business School Supplement 321-122, March 2021.
- September 2, 2020
- Article
How to Pay for Public Option Without Tax Hike
By: Regina E. Herzlinger and Richard Boxer
A bipartisan combination of the two parties’ most popular initiatives can expand health care coverage, significantly reduce costs, and enable freedom of choice, without raising taxes. Along the way, we can revitalize competition between public and private plans. Our... View Details
Keywords: Health Insurance; Public Option; Health Care and Treatment; Insurance; Cost Management; United States
Herzlinger, Regina E., and Richard Boxer. "How to Pay for Public Option Without Tax Hike." RealClearPolicy (September 2, 2020).
- March 2015 (Revised November 2017)
- Case
Bonitas
By: Regina E. Herzlinger and Natalie Kindred
Bonitas, a South African medical scheme (i.e., health insurer), must navigate highly restrictive regulations that make it difficult for Bonitas to innovate, grow, and compete with market leader Discovery as well as providers of alternative insurance products. Bonitas... View Details
Keywords: Health Insurance; Health Care; South Africa; Medical Scheme; Public Policy; Bonitas; Bonitas Medical Fund; National Health Insurance; Health; Health Care and Treatment; Insurance; Policy; Health Industry; Insurance Industry; South Africa; Johannesburg; Africa
Herzlinger, Regina E., and Natalie Kindred. "Bonitas." Harvard Business School Case 315-020, March 2015. (Revised November 2017.)
- August 2014 (Revised February 2021)
- Case
Hospital for Special Surgery (A)
By: Regina E. Herzlinger and Stacy Schwartz
Hospital for Special Surgery, a focused factory for orthopedics and joint disease, is contemplating various growth options: further growth in the United Kingdom's National Health Services, management of hospitals in the United States, and/or hospital consulting.... View Details
Keywords: Health Care and Treatment; Nonprofit Organizations; Growth and Development Strategy; Cross-Cultural and Cross-Border Issues; Expansion; Health Industry; United Kingdom; United States
Herzlinger, Regina E., and Stacy Schwartz. "Hospital for Special Surgery (A)." Harvard Business School Case 315-012, August 2014. (Revised February 2021.)
- August 2014
- Case
Blue Cross Blue Shield of Florida, Inc.
By: Regina E. Herzlinger and Meng Li
Keywords: Health; Health Care Industry; Health Insurance; United States; Health Care and Treatment; Health Industry; United States; Florida
Herzlinger, Regina E., and Meng Li. "Blue Cross Blue Shield of Florida, Inc." Harvard Business School Case 315-009, August 2014.
- April 1995 (Revised August 1995)
- Supplement
Empire Blue Cross and Blue Shield (C)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Supplements the (A) case. View Details
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (C)." Harvard Business School Supplement 195-218, April 1995. (Revised August 1995.)
- September 2013 (Revised August 2014)
- Case
Ping An Health (PAH): Towards a Comprehensive Private Health Insurance Market in China
By: Regina E. Herzlinger and Da Liu
- March 1993
- Case
West Paces Medical Center
By: Regina E. Herzlinger and Sharon Kleefield
Keywords: Health Industry
Herzlinger, Regina E., and Sharon Kleefield. "West Paces Medical Center." Harvard Business School Case 193-139, March 1993.
- September 2012 (Revised August 2015)
- Case
Shanghai Pharmaceuticals
By: Regina E. Herzlinger and Natalie Kindred
Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details
Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Pharmaceutical Industry; Health Industry; Shanghai; United States; Europe
Herzlinger, Regina E., and Natalie Kindred. "Shanghai Pharmaceuticals." Harvard Business School Case 313-016, September 2012. (Revised August 2015.)
- May 2012 (Revised August 2014)
- Case
McKesson
By: Regina E. Herzlinger and Natalie Kindred
McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into... View Details
Keywords: Health Care Industry; Health Care Policy; Organizational Transformations; Health Services; Health Care and Treatment; Business Model; Service Operations; Change Management; Corporate Strategy; Information Technology; Policy; Pharmaceutical Industry; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "McKesson." Harvard Business School Case 312-002, May 2012. (Revised August 2014.)
- March 2011
- Article
An Angel Investor with an Agenda
By: Regina E. Herzlinger and Beatriz Muñoz-Seca
Keywords: Investment
Herzlinger, Regina E., and Beatriz Muñoz-Seca. "An Angel Investor with an Agenda." Harvard Business Review 89, no. 3 (March 2011).
- January 2010 (Revised August 2012)
- Background Note
Note on Telemedicine
By: Regina E. Herzlinger and Jillian Copeland
This note provides background in all the modalities of telemedicine. It accompanies the cases "Medtronic: Patient Management Initiative" (A) and (B), HBS Nos. 302-005 and 309-064. View Details
Keywords: Interactive Communication; Entrepreneurship; Health Care and Treatment; Technological Innovation; Information Technology; Health Industry; Telecommunications Industry
Herzlinger, Regina E., and Jillian Copeland. "Note on Telemedicine." Harvard Business School Background Note 310-075, January 2010. (Revised August 2012.)